Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | CNR1 | P21554 | 2/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | TRPV3 | Q8NET8 | 3/20 | 0.32 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.31 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9949886 | 0.90 | LMNA (0.44) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL2484741 | 0.88 | LMNA (0.54) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL2489804 | 0.88 | LMNA (0.54) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL2484735 | 0.88 | LMNA (0.54) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL11441647 | 0.86 | LMNA (0.48) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL110122 | 0.86 | LMNA (0.48) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL1619179 | 0.86 | LMNA (0.52) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL10487796 | 0.85 | LMNA (0.48) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL1290458 | 0.85 | LMNA (0.46) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL4776978 | 0.84 | LMNA (0.50) | LMNACNR1ADRA1ATDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264382-A1 | COLLECTOR COMPOSITION FOR ORE BENEFICIATION | ArrMaz Products Inc. (US) | 2025-12-26 | — | — | WO | claimed |
| EP-4667107-A1 | COLLECTOR COMPOSITION FOR ORE BENEFICIATION | ArrMaz Products Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| US-12441694-B2 | Process for the preparation of methylene blue | DISHMAN CARBOGEN AMCIS LTD. (IN) | 2025-10-14 | — | — | US | claimed |
| WO-2025131704-A1 | WATER-BASED HYDRAULIC FLUIDS | CLARIANT INTERNATIONAL LTD (CH) | 2025-06-26 | — | — | WO | claimed |
| EP-4255414-B1 | COMPOSITION CONTAINING RANITIDINE HAVING A LOW IRON CONTENT | OPELLA HEALTHCARE GROUP SAS (FR) | 2025-02-05 | — | — | EP | claimed |
| CN-119285478-A | Cationic antistatic agent containing hydroxyl and ether bond and preparation method thereof | 中国日用化学研究院有限公司 | 2025-01-10 | — | — | CN | claimed |
| EP-4389292-A1 | COLLECTOR COMPOSITION FOR RARE EARTH ORE BENEFICIATION | ArrMaz Products Inc. (US) | 2024-06-26 | — | — | EP | claimed |
| EP-4389291-A1 | COLLECTOR COMPOSITION FOR LITHIUM ORE BENEFICIATION | ArrMaz Products Inc. (US) | 2024-06-26 | — | — | EP | claimed |
| US-20240174797-A1 | POLYESTERAMINES AND POLYESTERQUATS | ARKEMA FRANCE (FR) | 2024-05-30 | — | — | US | claimed |
| US-20240024278-A1 | COMPOSITION CONTAINING RANITIDINE HAVING A LOW IRON CONTENT | SANOFI CHIMIE (FR) | 2024-01-25 | — | — | US | claimed |
| EP-2928992-A1 | ADDITIVE COMPOSITIONS AND INDUSTRIAL PROCESS FLUIDS | Fuchs Petrolub SE (DE) | 2015-10-14 | — | — | EP | claimed |
| EP-2912216-A1 | DYEABLE AND FLAME-RETARDED THERMOPLASTIC POLYURETHANE FIBERS | Lubrizol Advanced Materials, Inc. (US) | 2015-09-02 | — | — | EP | claimed |
| WO-2015116233-A1 | ADDITIVE COMPOSITIONS AND INDUSTRIAL PROCESS FLUIDS | FUCHS PETROLUB SE (DE) | 2015-08-06 | — | — | WO | claimed |
| WO-2014066037-A1 | DYEABLE AND FLAME-RETARDED THERMOPLASTIC POLYURETHANE FIBERS | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2014-05-01 | — | — | WO | claimed |
| US-20130217780-A1 | Biostatic Neutralizing Composition for Aqueous Fluids | ARKEMA FRANCE (FR) | 2013-08-22 | — | — | US | claimed |
| EP-2621867-A1 | BIOSTATIC NEUTRALIZING COMPOSITION FOR AQUEOUS FLUIDS | Arkema France (FR) | 2013-08-07 | — | — | EP | claimed |
| WO-2012045958-A1 | BIOSTATIC NEUTRALIZING COMPOSITION FOR AQUEOUS FLUIDS | ARKEMA FRANCE (FR) | 2012-04-12 | — | — | WO | claimed |
| US-20090156077-A1 | Non-woven web having isotropic mechanical properties and preparation method of the same | HYUNDAI MOTOR COMPANY (KR) | 2009-06-18 | — | — | US | claimed |
| WO-2006115393-A1 | AUTO-STOPPING ABRASIVE COMPOSITION FOR POLISHING HIGH STEP HEIGHT OXIDE LAYER | TECHNO SEMICHEM CO., LTD. (KR) | 2006-11-02 | — | — | WO | claimed |
| US-4759861-A | Consists of an aliphatic mono- or di-carboxylic acid, a dimer or trimer of said dicarboxylic acid, petroleum sulfonic acid and naphthenic acid or salt | NIPPON OIL CO., LTD. (JP) | 1988-07-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130217780-A1 | Biostatic Neutralizing Composition for Aqueous Fluids | MME, NEFM, COMT | LMNA 4297/4885CNR1 1562/4885ADRA1A 258/4885 |
| US-20240174797-A1 | POLYESTERAMINES AND POLYESTERQUATS | PUF60, CUTA, ASH2L | LMNA 2059/4885CNR1 4524/4885ADRA1A 4539/4885 |
| US-20240024278-A1 | COMPOSITION CONTAINING RANITIDINE HAVING A LOW IRON CONTENT | TFRC, HAMP, HRH2 | LMNA 3477/4885CNR1 1883/4885ADRA1A 2339/4885 |
| US-12441694-B2 | Process for the preparation of methylene blue | B2M, LMNB2, LMNA | LMNA 3/4885CNR1 4618/4885ADRA1A 3136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.